Authors | علی یعقوبیان,مسلم ستوده خواه,فاطمه پارسا |
---|---|
Journal | RSC Advances |
Page number | 26091 |
Volume number | 14 |
IF | 3.9 |
Paper Type | Full Paper |
Published At | 2024-08-19 |
Journal Grade | Scientific - research |
Journal Type | Electronic |
Journal Country | Iran, Islamic Republic Of |
Journal Index | SCOPUS ,JCR |
Abstract
This study reports a novel magnetic and porous nanocomposite, Fe3O4@CS@UIO-66-NH2(Zr), developed by growing a zirconium-based metal–organic framework on magnetite–chitosan. It is designed for targeted and delayed pantoprazole delivery, the nanocomposite exhibits pH-sensitive behavior and functions as an efficient nanocarrier. The synthesis process involved coating magnetite nanoparticles with chitosan, followed by the growth of UIO-66-NH2(Zr) on the coated nanoparticles. The nanocomposite demonstrated high drug loading efficiency (DLE) in acetate buffer (pH 5.0) and deionized water, with loading percentages of 79% and 75%, respectively, within 48 hours. The corresponding drug loading content (DLC) was approximately 14% and 10%. The Freundlich and Langmuir models accurately described the multilayer adsorption behavior of pantoprazole on the nanocomposite's active sites. BET and EDX-map analyses confirmed that the drug was loaded into the nanocomposite's pores and uniformly adsorbed on its surface. The drug release kinetics were best described by the pseudo-secondorder model. Due to its porosity, magnetic properties, and favorable drug loading characteristics, the Fe3O4@CS@UIO-66-NH2(Zr) nanocomposite shows potential as an efficient targeted drug delivery system for in vivo applications.
tags: Metal-organic framework, Proton pump inhibitors (PPIs), magnetite-chitosan, pantoprazole, Targeted drug delivery.